Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT-Reference-Cited by-同舟云学术

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT

Published:2023-01-04 Issue:1 Volume:14 Page:
ISSN:2150-5594
Container-title:Virulence
language:en
Short-container-title:Virulence

Author:

Zhang Lu¹,Yang Liu¹,Gao Yuanjiao¹,Bi Xiaoyue¹,Lin Yanjie²,Deng Wen¹,Jiang Tingting¹,Lu Yao¹,Hao Hongxiao¹,Wan Gang³,Yi Wei⁴^ORCID,Xie Yao¹²^ORCID,Li Minghui¹²^ORCID

Affiliation:

1. Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China

2. Department of Medical Record Statistics, Beijing Ditan Hospital, Capital Medical University, Beijing, China

3. Department of Gynecology and Obstetrics, Beijing Ditan Hospital, Capital Medical University, Beijing, China

4. Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China

Funder

Beijing Hospitals Authority Clinical medicine Development of special funding support

National Science and Technology Major Project of China

High-level Public Health Technical Personnel Training Program of Beijing Municipal Health Commission

Special Public Health Project for Health Development in Capital

The Digestive Medical Coordinated Development Center of Beijing Hospitals Authority

Project supported by Beijing science and technology commission

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Parasitology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21505594.2022.2158710

Reference40 articles.

1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)

5. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 Mar.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study;eClinicalMedicine;2024-02

2. Emerging Trends in the Application of Extracellular Vesicles as Novel Oral Delivery Vehicles for Therapeutics in Inflammatory Diseases;INT J NANOMED;2024

3. Strategy for immunological analysis of pro-inflammatory cytokine marker studies with chronic hepatitis B virus in Southwestern region of Saudi Arabia;Journal of Infection and Public Health;2023-10

4. Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B;Infection and Drug Resistance;2023-08

5. Advances in the Therapeutic Applications of Plant-Derived Exosomes in the Treatment of Inflammatory Diseases;Biomedicines;2023-05-27